Article

jdsupra.com on 2020-07-02 18:47

FDA quietly withdraws plans for a Devices Referencing Drugs regulatory approval pathway

The U.S. Food and Drug Administration recently withdrew its plans for a “Devices Referencing Drugs” (DRD) regulatory approval pathway, which it had ...

Related news

FDA’s Proposed New Pathway for Devices Referencing Drugs (DRDs)jdsupra.com
New Regulatory Pathway for Cannabidiol Products May be Forthcoming jdsupra.com
Parsing products: FDA regulatory policy for multi-function medical devices jdsupra.com
FDA Initiates Expedited Access Pathway Program for Medical Devices via Final Guidance Document jdsupra.com
Spalding
Look Before You Leap – Early Determination of Product Classification and Regulatory Pathway for FDA-Regulated Products jdsupra.com
Seeking to reduce premarket burdens, FDA proposes to expand Abbreviated 510(k) Pathway for certain devices jdsupra.com
CMS Proposes Basic Changes for Medicare Coverage, Including a New Reimbursement Pathway for FDA-designated Breakthrough Medical Devices jdsupra.com
Reg
FDA Issues Final Guidance Eliminating Regulatory Controls on Medical Device Data Systems, Imaging Storage Devices, and Imaging Communications Devices jdsupra.com
FDA Will Not Enforce Regulatory Controls for Medical Device Data Systems and Two Other Health IT Devices jdsupra.com
Avoiding Misbranding: Words Matter When Describing the Regulatory Status of 510(k) Cleared Devices and Registered Device Establishments jdsupra.com
How Smart is it for Medical Devices to Learn New Tricks? The FDA Seeks Feedback On Its Proposed Regulatory Framework for Artificial Intelligence/Machine Learning-Based Medical Devices jdsupra.com
California , United States , Switzerland
Navigating the U.S. FDA regulatory clearance for digital medical devices: the 510(k) and Pre-Cert program jdsupra.com
California , United States , Switzerland
[Audio] Nota Bene Episode 71: Shifting Regulatory Landscapes at the FDA: Cannabis, Vaping and Intelligent Medical Devices with Allison Fulton jdsupra.com
California , United States , Switzerland
FDA to regulate more AI & software tools as devices, guidance indicates - FDA also seeks new digital health regulatory paradigm in Pre-Cert Program report jdsupra.com
Cures
The Other Shoe Drops: FDA Withdraws 30-Year-Old Homeopathic Drug Enforcement Policy and Puts Industry on Notice of Further Regulatory Pressure jdsupra.com
California , United States , Switzerland , Shu
MAS Withdraws Fund Manager’s Regulatory Approval jdsupra.com
Singapore
Regulatory Filings Hint At New Roku Devices variety.com
Silicon Valley
Hong Kong’s SFC Lays Out Regulatory Pathway for Tokenisation jdsupra.com
Hong Kong
Modernization of the 510(k) Pathway to Market Medical Devices jdsupra.com
California , United States , Switzerland
A Pathway for Medicare Coverage for Breakthrough Devices: Take Two jdsupra.com